Impulse Control Problems Linked to Antipsychotic, FDA WarnsImpulse Control Problems Linked to Antipsychotic, FDA Warns

The FDA is warning of impulse control problems associated with the atypical antipsychotic aripiprazole. News Alerts
Source: Medscape Psychiatry Headlines - Category: Psychiatry Tags: Psychiatry News Alert Source Type: news
More News: Abilify | Psychiatry | Warnings